Dienstag Penina, Halaseh Rana, Tzukert Keren, Imam Ashraf, Khalaileh Abed, Dienstag Aryeh
Department of Anesthesia, Hadassah Hebrew University School of Medicine, Jerusalem, Israel.
Department of Psychiatry, Hadassah Hebrew University School of Medicine, Jerusalem, Israel.
Am J Transplant. 2024 Aug;24(8):1342-1347. doi: 10.1016/j.ajt.2024.04.005. Epub 2024 Apr 17.
Living donor kidney transplantation (LDKT) is one of the most effective treatment options for people with end-stage renal disease. Traditionally, LDKT can be either "directed" or "nondirected," based on whether the recipient is specified by the donor. Recently, there has been an increase in conditional and semidirected live kidney donation among strangers, where the donor specifies the characteristics of the recipient whom they wish to donate to. This practice has both gained popularity and sparked controversy in the state of Israel through the nonprofit organization Matnat Chaim. We analyze the ethical implications of this practice by applying traditional principles of medical ethics to conditional LDKT. Although semidirected and conditional LDKT presents some ethical challenges, overall, its practice effectively aligns with core ethical principles. The donors' right to make stipulations respects the donor's autonomy, the practice avoids harm and benefits both donor and recipient, and justice and utility are upheld as the practice specifically benefits marginalized patients and optimizes resource utilization. Finally, we present data from our institution demonstrating how conditional LDKT increased transplantation for all ethnic groups; Jewish recipients of LDKT increased by 151.32% (P = .034) Arab recipients of LDKT increased by 111.11% (P = .036).
活体供肾移植(LDKT)是终末期肾病患者最有效的治疗选择之一。传统上,根据供体是否指定受体,LDKT可分为“定向”或“非定向”。最近,陌生人之间的有条件和半定向活体肾捐赠有所增加,即供体指定他们希望捐赠给的受体的特征。通过非营利组织Matnat Chaim,这种做法在以色列既受到欢迎,也引发了争议。我们通过将传统医学伦理原则应用于有条件的LDKT来分析这种做法的伦理影响。虽然半定向和有条件的LDKT带来了一些伦理挑战,但总体而言,其做法有效地符合核心伦理原则。供体做出规定的权利尊重了供体的自主权,这种做法避免了伤害,对供体和受体都有益,并且维护了正义和效用,因为这种做法特别有利于边缘化患者并优化资源利用。最后,我们展示了来自我们机构的数据,表明有条件的LDKT如何增加了所有种族群体的移植率;LDKT的犹太受体增加了151.32%(P = .034),LDKT的阿拉伯受体增加了111.11%(P = .036)。